4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-24-021731
EVP, CHIEF FINANCIAL OFFICER sold 9,733 shares at $15.28 ($148,720)
- EVP, CHIEF FINANCIAL OFFICER acquired 18,904 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2024-08-16 | Grant or award | +5,275 | 39,839 | D | ||
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2024-08-16 | Grant or award | +13,629 | 53,468 | D | ||
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2024-08-19 | Sale | −9,733 | $15.28 | $148,720 | 43,735 | D |
| Open-market sales · 9,733 sh · avg $15.28 · $148,720 | |||||||
Loading xslF345X05/form4-08202024_100820.xml…